Wingspire Capital Provides $45 Million Revolving Credit Facility to Medical Device Maker

ATLANTA – July 6, 2026 — Wingspire Capital is pleased to announce it has provided a $45 million revolving credit facility to a global medical device maker that develops, manufactures, and markets a portfolio of spinal surgery products.

Proceeds are being used to refinance the previous capital structure. Wingspire Capital provided a more flexible credit facility with greater liquidity to support the company’s continued growth. 

“We enjoyed working closely with the borrower and sponsor on a creative and nimble solution, allowing the borrower to focus on growing its business,” said Katie Thornett, Managing Director at Wingspire Capital.

Wingspire Capital offers one-stop solutions of up to $200 million for middle market companies, including revolving lines of credit, asset-backed term loans, first-out revolvers & term loans, equipment loans and leases, sale lease-backs, and lender finance. Industries financed include business services, consumer products, e-commerce & retail, food & beverage, healthcare, manufacturing, distribution, transportation & logistics, automotive, technology applications and financial services. Wingspire Capital operates in two business units: Wingspire Corporate Finance and Wingspire Equipment Finance.

Wingspire Capital is a portfolio company of Blue Owl Capital Corporation (NYSE: OBDC). OBDC is externally managed by Blue Owl Credit Advisors LLC, an indirect affiliate of Blue Owl Capital, Inc. (NYSE: OWL). Blue Owl Capital, Inc. is a global alternative asset manager with $315 billion of assets under management as of March 31, 2026. For further information about Wingspire Capital, visit www.wingspirecapital.com.